BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26384307)

  • 1. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
    Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
    Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling.
    Xiong S; Klausen C; Cheng JC; Leung PC
    Oncotarget; 2016 Jun; 7(26):40060-40072. PubMed ID: 27223076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signaling.
    Xiong S; Klausen C; Cheng JC; Leung PCK
    Cell Signal; 2017 Jun; 34():92-101. PubMed ID: 28336232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activin A, B, and AB increase human trophoblast cell invasion by up-regulating N-cadherin.
    Li Y; Klausen C; Cheng JC; Zhu H; Leung PC
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2216-25. PubMed ID: 25105734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1/2 signaling pathways.
    Xiong S; Cheng JC; Klausen C; Zhao J; Leung PC
    Oncotarget; 2016 Sep; 7(38):61262-61272. PubMed ID: 27542208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Morphogenetic Protein 2 Promotes Human Trophoblast Cell Invasion by Inducing Activin A Production.
    Zhao HJ; Chang HM; Zhu H; Klausen C; Li Y; Leung PCK
    Endocrinology; 2018 Jul; 159(7):2815-2825. PubMed ID: 29846546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells.
    Shi FT; Cheung AP; Leung PC
    Endocrinology; 2009 Aug; 150(8):3540-6. PubMed ID: 19423755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
    Banz-Jansen C; Münchow B; Diedrich K; Finas D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
    Xinxin H; Meng Z; Guiyu Z
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
    Di Simone N; Schneyer AL; Caliandro D; Castellani R; Caruso A
    Mol Cell Endocrinol; 2002 Jun; 192(1-2):187-95. PubMed ID: 12088879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
    Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
    Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.
    Chen Y; Saini S; Zaman MS; Hirata H; Shahryari V; Deng G; Dahiya R
    Mol Carcinog; 2011 Jan; 50(1):16-23. PubMed ID: 20886547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
    Song H; Guo B; Zhang J; Song C
    Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
    Haughian JM; Bradford AP
    J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endogenous growth differentiation factor 9 on activin A-induced inhibin B production in human granulosa-lutein cells.
    Shi FT; Cheung AP; Huang HF; Leung PC
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5108-16. PubMed ID: 19846738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.